Status:
RECRUITING
The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes
Lead Sponsor:
Newlife Fertility Centre
Conditions:
Infertility
Infertility,Female
Eligibility:
FEMALE
18-38 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to test the effect of granulocyte colony-stimulating factor (G-CSF, A.K.A. Filgrastim) in infertility patients undergoing in vitro fertilization (IVF) treatment. The...
Detailed Description
Please see uploaded study protocol.
Eligibility Criteria
Inclusion
- Recruited subjects will either be undergoing a fresh IVF-ET cycle in which the embryo(s) generated from the initial treatment cycle are transferred during that same cycle (i.e., on day 5 or 6 post-egg retrieval) or an FET cycle in which the embryo(s) transferred were generated in a previous IVF cycle and were cryopreserved for subsequent warming and transfer.
Exclusion
- Patients with uterine factor or severe male factor infertility will be excluded.
- Patients who have had previous IVF failures will be excluded.
Key Trial Info
Start Date :
March 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 10 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06174298
Start Date
March 20 2024
End Date
January 10 2025
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Newlife Fertility Centre
Mississauga, Ontario, Canada, L4Z 2G6